NVAX - Latest News
Novavax, Inc. (NVAX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.46B. Beta to the broader market is 2.41.
The article list below shows the most recent NVAX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent NVAX Headlines
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
zacks.com - Jun 24, 2026
In the closing of the recent trading day, Novavax (NVAX) stood at $8. 9, denoting a -1.
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM
globenewswire.com - Jun 24, 2026
RALEIGH, N. C.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
zacks.com - Jun 23, 2026
Novavax (NVAX) has been one of the stocks most watched by Zacks. com users lately.
Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know
zacks.com - Jun 18, 2026
Novavax (NVAX) closed the most recent trading day at $9. 13, moving 3.
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
247wallst.com - Jun 16, 2026
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.
How News Affects NVAX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track NVAX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked NVAX news questions
- What is the latest NVAX news headline?
- The most recent NVAX headline (Jun 24, 2026) is "Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the NVAX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What NVAX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual NVAX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.